|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1993-5-20
|
|
pubmed:abstractText |
Retinopathy of prematurity (ROP) is the leading cause of blindness among premature infants. A recent National Eye Institute-sponsored prospective, multicenter trial investigating the use of cryotherapy for treatment of ROP demonstrates a significant reduction in blindness and low vision for patients with sight-threatening (stage 3+) ROP.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0031-4005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
859-66
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8474803-Computer Simulation,
pubmed-meshheading:8474803-Cost Savings,
pubmed-meshheading:8474803-Cost-Benefit Analysis,
pubmed-meshheading:8474803-Cryosurgery,
pubmed-meshheading:8474803-Humans,
pubmed-meshheading:8474803-Infant, Newborn,
pubmed-meshheading:8474803-Models, Theoretical,
pubmed-meshheading:8474803-Neonatal Screening,
pubmed-meshheading:8474803-Retinopathy of Prematurity,
pubmed-meshheading:8474803-Sensitivity and Specificity
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity.
|
|
pubmed:affiliation |
Worthen Center for Eye Care Research, Georgetown University Medical Center, Washington, DC 20007.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
